Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Receivables - Net: 2019-2024

Historic Receivables - Net for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $229,000.

  • Benitec Biopharma's Receivables - Net fell 94.34% to $3,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $3,000, marking a year-over-year decrease of 94.34%. This contributed to the annual value of $229,000 for FY2024, which is 316.36% up from last year.
  • Per Benitec Biopharma's latest filing, its Receivables - Net stood at $229,000 for FY2024, which was up 316.36% from $55,000 recorded in FY2023.
  • Over the past 5 years, Benitec Biopharma's Receivables - Net peaked at $229,000 during FY2024, and registered a low of $3,000 during FY2022.
  • For the 3-year period, Benitec Biopharma's Receivables - Net averaged around $95,667, with its median value being $55,000 (2023).
  • Its Receivables - Net has fluctuated over the past 5 years, first slumped by 97.67% in 2020, then surged by 1,733.33% in 2023.
  • Benitec Biopharma's Receivables - Net (Yearly) stood at $59,000 in 2020, then tumbled by 57.63% to $25,000 in 2021, then tumbled by 88.00% to $3,000 in 2022, then soared by 1,733.33% to $55,000 in 2023, then spiked by 316.36% to $229,000 in 2024.